Literature DB >> 25552551

Association of drug susceptibility testing results for first- and second-line drugs with treatment outcomes in patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Wang Hong-min1, Zhang Xiao-Hong2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25552551     DOI： 10.1093/cid/ciu1169

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China.

Authors:  Xubin Zheng; Rongrong Zheng; Yi Hu; Jim Werngren; Lina Davies Forsman; Mikael Mansjö; Biao Xu; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates.

Authors:  Kamal Singh; Swati Sharma; Tuhina Banerjee; Ankush Gupta; Shampa Anupurba
Journal:  BMC Microbiol       Date:  2022-10-03       Impact factor: 4.465

3.  Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism.

Authors:  Wei Wang; Bo Qin; Justyna Aleksandra Wojdyla; Meitian Wang; Xiaopan Gao; Sheng Cui
Journal:  IUCrJ       Date:  2018-06-22       Impact factor: 4.769
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.